Organization
Department of Pediatrics and Adolescent Medicine
3 abstracts
Abstract
Biological Medicines for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication (BIOMEDE): Final results of an international randomized phase II platform trial comparing 3 targeted therapies in combination with radiotherapy from ITCC, SIOPE-Brain and ANZCHOG.Org: Gustave Roussy Cancer Centre, University College London Hospital NHS Trust and Great Ormond Street Hospital, Department of Women's and Children's Health, Princess Maxima Center, Necker Hospital,
Abstract
Reduction in Curie score in neuroblastoma patients treated with naxitamab.Org: Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Hong Kong Children's Hospital, The University of Hong Kong, The Hospital for Sick Children,
Abstract
LOGGIC/FIREFLY-2: A phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.Org: Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), Children's National Hospital, Washington, DC, Seattle Children’s Hospital, Orlando Health Arnold Palmer Hospital for Children,